Holyvolt Raises $45M for AI Battery Materials Discovery

Mathias Ingvarsson bought an experimental history when Holyvolt acquired Wildcat Discovery Technologies in 2026. The Stockholm battery-materials company is now funding the work that history can support: AI models connected to a laboratory that makes cells, tests them and uses the results to choose the next experiments.

Holyvolt announced $45M in financing on October 15, 2026, naming Zone II, Course Corrected and finance-sector angel investors as backers. The company plans to expand its scientific team, laboratory capacity and AI capabilities while advancing DRX, its nickel- and cobalt-free cathode family, toward commercialization beginning in 2027. The financing puts a practical question behind the AI story: how much useful experimental knowledge can a materials developer carry into its customer's next production decision?

A younger company with an older laboratory

Holyvolt was founded in Sweden in 2022. Its acquisition of Wildcat Discovery Technologies brought an established battery-materials research operation into a company already developing screen-printing processes for energy technologies. Holyvolt's March acquisition explanation describes the combination as a way to connect accelerated materials discovery with manufacturing development. That pairing matters because a promising formulation still needs a process through which somebody can make it consistently.

The funding release describes Wildcat's platform as the product of 18 years of experimental work, with more than 225 projects completed for over 85 customers. These are company-reported figures for the platform's accumulated history, rather than evidence that Holyvolt itself has operated for 18 years. Their commercial significance lies in the continuity of the research operation: experiments become more useful when later work can learn from how earlier cells behaved.

Ingvarsson is Holyvolt's founder and CEO. Hans Victor is identified as a co-founder and board member on the official management page, while co-founder Peter Lilliehöök's business-council record corroborates his founding role. The technology leadership includes CTO Robert Erdmann. The October announcement also identifies Steven Prast as COO and Dee Strand as CSO, bringing manufacturing, automation and battery-materials experience into the same development effort. Keeping those disciplines in conversation is part of the work the financing supports.

Where the AI meets a physical cell

Holyvolt calls the combined system its Discovery Engine. Models identify candidate materials, automated laboratory equipment builds and cycles cells, and the resulting observations feed subsequent experimental choices. The company is putting money into both the models and the physical capacity around them. That is a different spending pattern from improving prediction software while leaving the testing operation to somebody else.

For a customer, the useful output of this process is evidence about a material's behavior. A research team may need to choose which formulation deserves another experiment, which trade-off is acceptable or when to stop pursuing a candidate. A failed test can inform that choice if its conditions and result remain available to later work. The economic value comes from making the next decision with better information, including information that rules something out.

Holyvolt's published acquisition rationale describes machine learning and automated experiments as a feedback process. It also connects that research with screen-printing and water-based manufacturing development. Those activities have related purposes, but a reader should keep the claims separate: learning more quickly about a formulation, demonstrating a manufacturing process and producing a commercial battery at an acceptable cost are different achievements. The financing gives the team resources to work across those handoffs; the announcement supplies no independently validated commercial yield or customer qualification result for DRX.

DRX gives the research a customer destination

DRX stands for disordered rocksalt. Holyvolt is developing the cathode family without nickel or cobalt and intends to begin commercialization in 2027, initially for defense applications and later for larger mobility markets. That sequence gives the research effort a defined market direction while leaving the commercial outcome open. A planned launch date does not identify a qualified customer, a signed supply agreement or a completed production ramp.

The supply-chain argument reaches beyond an individual chemistry. The International Energy Agency's Global EV Outlook 2026 analysis of battery manufacturing describes a market concentrated in established Asian producers, alongside difficult economics for companies trying to diversify materials supply. Its analysis also explains that additional manufacturing capacity takes time to become productive output. For an emerging supplier, the challenge includes earning a place in customers' engineering plans while existing suppliers keep competing on price and performance.

Removing nickel and cobalt from a cathode changes the material choices involved in making it. Supply-chain resilience still depends on where the remaining inputs come from, how they are processed and who can manufacture the finished material. Holyvolt's stated aim is to develop chemistries using materials that can be sourced outside China. The relevant customer conversation therefore extends from the cell's behavior to the practical availability of the production chain that would supply it.

What the financing puts into motion

The named backers are Zone II, Course Corrected, also known as CC.VC, and unnamed finance-sector angels. Holyvolt's release identifies Fifth Wall as an existing investor. It does not disclose a formal round stage or a lead investor, so the $45M announcement should remain a financing announcement without an invented Series label. Earlier closes also make a lifetime funding total unsafe to construct by adding published headlines together.

The allocation is concrete even where the financial terms remain private: more AI capability, more laboratory capacity, a larger scientific team and continued DRX development. Those uses place experimental selection and physical verification inside the same funded program. An additional scientist or testing slot can change which questions the organization is able to pursue, provided the findings remain useful to the people designing the next cell or production process.

Holyvolt's operating choices will also determine how research reaches industrial partners. The company already describes materials development and manufacturing development as connected activities, and its existing Wildcat operation gives that ambition a physical setting. As the team works toward its 2027 DRX plans, the evidence moving out of the laboratory will enter increasingly specific conversations: which application needs the material, which performance trade-offs the customer can accept and how a manufacturing partner can reproduce the result.